Colleen Nelson
Queensland University of Technology
H-index: 69
Oceania-Australia
Top articles of Colleen Nelson
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Valine Catabolism Drives Bioenergetic and Lipogenic Fuel Plasticity in Prostate Cancer | bioRxiv | Charles L Bidgood Lisa K Philp Anja Rockstroh Melanie Lehman Colleen C Nelson | 2024 |
Evexomostat: A novel therapeutic in development for the treatment of prostate cancer | Cancer Research | Peter Cornelius Benjamin Mayes Bradley J Carver James Shanahan Jennifer Gunter | 2023/4/4 |
Unravelling the Role of Iroquois Homeobox 4 and its Interplay with Androgen Receptor in Prostate Cancer | Research Square | Panchadsaram Janaththani Gregor Tevz Achala Fernando Adil Malik Anja Rockstroh | 2023/10/24 |
Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts | Current Oncology | Patrick B Thomas Saeid Alinezhad Andre Joshi Katrina Sweeney Brian WC Tse | 2023/10/24 |
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer | The Prostate | Mark N Adams Laura V Croft Aaron Urquhart Mohamed Ashick Mohamed Saleem Anja Rockstroh | 2023/5 |
Pseudo-grading of tumor subclones using phenotype algebra | bioRxiv | Namrata Bhattacharya Anja Rockstroh Sanket Suhas Deshpande Sam Koshy Thomas Smriti Chawla | 2022/12/30 |
Gene expression based inference of cancer drug sensitivity | Nature communications | Smriti Chawla Anja Rockstroh Melanie Lehman Ellca Ratther Atishay Jain | 2022/9/27 |
Isomeric lipid signatures reveal compartmentalized fatty acid metabolism in cancer | Journal of lipid research | Reuben SE Young Andrew P Bowman Kaylyn D Tousignant Berwyck LJ Poad Jennifer H Gunter | 2022/6/1 |
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation | Breast Cancer Research | Yu Hin Tang Anja Rockstroh Kamil A Sokolowski Layla-Rose Lynam Melanie Lehman | 2022/1/25 |
Gene expression based inference of drug resistance in cancer | bioRxiv | Smriti Chawla Anja Rockstroh Melanie Lehman Ellca Rather Atishay Jain | 2021/11/19 |
Big data analytics in single‐cell transcriptomics: Five grand opportunities | Namrata Bhattacharya Colleen C Nelson Gaurav Ahuja Debarka Sengupta | 2021/7 | |
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype | PeerJ | Patrick B Thomas Penny Jeffery Manuel D Gahete Eliza Whiteside Carina Walpole | 2021/2/1 |
In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer | Science advances | Nathalie Bock Thomas Kryza Ali Shokoohmand Joan Röhl Akhilandeshwari Ravichandran | 2021/6/30 |
Adipokine Hormone Axes: Uncovering A Critical Role in Advanced Prostate Cancer Progression | Scientific Symposium of OzMRS (Australasian Metastasis Research Society) | Lisa Philp Anja Rockstroh Melanie Lehman Colleen Nelson | 2021/6/21 |
Leptin antagonism inhibits prostate cancer xenograft growth and progression | Endocrine-related cancer | Lisa K Philp Anja Rockstroh Martin C Sadowski Atefeh Taherian Fard Melanie Lehman | 2021/5/1 |
Apocryphal FADS2 activity promotes fatty acid diversification in cancer | Cell reports | Reuben SE Young Andrew P Bowman Elizabeth D Williams Kaylyn D Tousignant Charles L Bidgood | 2021/2/9 |
Metabolic plasticity in cancer activates apocryphal pathways for lipid desaturation | bioRxiv | Reuben SE Young Andrew P Bowman Elizabeth D Williams Kaylyn D Tousignant Charles L Bidgood | 2020/6/8 |
Transient Sox9 expression facilitates resistance to androgen-targeted therapy in prostate cancer | Clinical Cancer Research | Mannan Nouri Shabnam Massah Josselin Caradec Amy A Lubik Na Li | 2020/4/1 |
Adiponectin receptor activation inhibits prostate cancer xenograft growth | Endocrine-Related Cancer | Lisa K Philp Anja Rockstroh Melanie Lehman Martin C Sadowski Nenad Bartonicek | 2020/12/1 |
The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer | Molecular oncology | Thomas Kryza Nathalie Bock Scott Lovell Anja Rockstroh Melanie L Lehman | 2020/1 |
